Health Canada Approves First Special Access Program Requests for Psilocybin
By Therapsil
This page summarizes Health Canada’s first known Special Access Program authorization for psilocybin, issued to support treatment for six patients experiencing end-of-life distress. It describes the SAP request process, the clinicians involved, and the supply and legal support used.